We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ideagen Plc | LSE:IDEA | London | Ordinary Share | GB00B0CM0C50 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 349.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
22/7/2014 10:42 | Nothing wrong with these results at all IMO and am amazed at the selling but each to their own,good entry price as it appears a decent support level here now IMO | cheshire man | |
22/7/2014 10:11 | Thanks GHF, guess trading updates on contract wins should be good price drivers as per earlier this year. | hutch_pod | |
22/7/2014 09:53 | Results look pretty decent to me. Been buying back the shares I sold at 44p. | stegrego | |
22/7/2014 09:42 | Yes Hutch, absolutely nothing to worry about and simply appears to be the market reaction that many small caps have experienced recently on release of results. This snippet from the RNS says it all.... "The results represent the Group's fifth consecutive year of revenue and adjusted EPS growth and cash generation from operations." I await upgraded forecasts from FinnCap but they re-iterated their 50p price target this morning & confirmed results "precisely in line with expectations". IDEAs net cash of £4.0m was (as mentioned) 5% ahead of forecast. Great levels of recurring revenues and outlook with excellent management team. Regards, GHF | glasshalfull | |
22/7/2014 09:35 | Yes, the increase in recurring revenues from £3.1m to £5.1m is encouraging. I also remember an old quote from the CEO talking about £50m revenue ambitions based on supplying half of the 200 NHS trusts. Hopefully the price will stabilise quickly and reestablish the uptrend. Currently looks like the 14 January drop on in-ine figures.. | hutch_pod | |
22/7/2014 08:19 | I like the recurring revenue and earnings visibility here, makes up a significant proportion of my overall holdings, very comfortable to hold long term | chizgreen68 | |
22/7/2014 08:16 | Results bang in line with expectations & another year of double digit growth (in terms of adj diluted EPS). 2.0p EPS pencilled in for this year for earnings growth of 20%. Well done to DH & team. Regards, GHF | glasshalfull | |
21/7/2014 20:40 | looking for a nicely positive RNS tomorrow, GL all | chizgreen68 | |
18/7/2014 12:20 | I noticed the current lows seemed to be triggered by the 25 June acquisition announcement, which i guess is just market caution | hutch_pod | |
11/7/2014 09:35 | Based on fcast eps 34.5p is fair value, so hopefully we will see higher earnings / higher fcast growth ;0 | chizgreen68 | |
11/7/2014 09:28 | Morning chizgreen, certainly deserves a decent rating given the growth etc imv. | battlebus2 | |
11/7/2014 09:17 | morning BB2, does look like it bottomed out at 32.5, be nice to see a return to the 40s post results | chizgreen68 | |
11/7/2014 09:10 | Ticking up ahead of the results :)) | battlebus2 | |
10/7/2014 20:23 | results RNS on 22/07 | chizgreen68 | |
10/7/2014 20:07 | Market for techs down generally | welsheagle | |
09/7/2014 14:22 | still in freefall, hopefully news around 16th | chizgreen68 | |
04/7/2014 10:21 | Trading update wasn't all that long ago, shouldn't think much could have changed for the worse since then. | paleje | |
04/7/2014 09:53 | Im guessing MMs getting shares cheap prior to the results - there appears to be no negative news flow. But obviously thats just a guess | chizgreen68 | |
04/7/2014 09:50 | Is there a reason for the falls recently? | craigo3 | |
03/7/2014 10:28 | we must be due some results in the next week or so? | chizgreen68 | |
25/6/2014 07:55 | Another great acquisition.... EIBS Ltd Ideagen (AIM; IDEA), a leading supplier of Information Management Software to regulated industries, is pleased to announce the acquisition of the entire issued share capital of EIBS Limited ("EIBS") for a net cash consideration of GBP1.25 million ("the Acquisition") payable from Ideagen's existing cash reserves. Highlights -- EIBS is a software company that has developed proprietary Information Portal, Internet and Mobile solutions for the NHS and numerous public sector, not for profit and commercial organisations. -- EIBS has approximately 140 customers, including 40 NHS Trusts. -- The Acquisition: - delivers strong internet, mobile and portal IP that can be integrated across the Group's product portfolio - further consolidates the Group's position in the NHS providing 40 trusts as customers - increases the Group's customer base within a number of regulated market sectors - delivers significant cross-selling and up-selling opportunities for the Group - rapidly accelerates the delivery of the Group's mobile product strategy -- Ideagen and EIBS have identified approximately GBP0.4m of synergies, which the Directors anticipate will be achievable during the 12 month period ending 30 April 2016 and will deliver significant operational efficiencies and cost savings across the enlarged Group -- the Acquisition is therefore expected to be earnings enhancing in the first full financial period following completion of the Acquisition -- Consideration: - total cash consideration of GBP1.55m - EIBS has net cash reserves of GBP0.3m, giving net cash consideration of GBP1.25m - the net consideration will be met from Ideagen's existing cash reserves -- In the year ended 31 July 2013 EIBS generated revenues of GBP1.6m and a loss before tax of GBP0.1m. Current recurring revenues are GBP0.9m per annum -- EIBS's Chief Technology Officer, Matt Burnett will remain with the enlarged Group and will be appointed the role of "Chief Technology Officer - Content Solutions" reporting directly to the CEO on completion of the Acquisition David Hornsby, CEO, commented; "I am delighted to announce the acquisition of EIBS which we believe will augment the Group, both strategically and financially, thereby enhancing shareholder value. EIBS has established an extremely compelling value proposition comprising strong IP and long-term relationships with its extensive customer base which includes a number of NHS trusts. "The combination of EIBS and Ideagen will enable the enlarged Group to rapidly develop new applications for our key markets and we believe the Acquisition provides an outstanding opportunity to leverage our position in the NHS and other regulated market sectors. We are confident that we can make the EIBS business significantly more profitable over the next 12 months as we integrate it into the rest of the Group." | battlebus2 | |
09/6/2014 13:08 | I will pick up some more later this month once I have some cash available to top up the ISA, I probably have too many already from a risk management perspective, but I really believe in the company long term | chizgreen68 | |
09/6/2014 13:04 | Summer lull. Best time to go looking for good value in growth stocks - next couple of months. | yump | |
09/6/2014 11:48 | The price is dropping on almost no volume. I have no idea why though | chizgreen68 | |
22/5/2014 16:38 | I had planned to attend but last minute circumstances prevented it. Would certainly attend next time though | janeann |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions